Pangolin Therapeutics develops a chemistry-driven platform to design novel small molecule therapeutics. Pangolin specializes in research in neurodegenerative diseases, including Parkinson's and Alzheimer's. The plaform is designed to target the disassembly of toxic protein oligomers during disease pathogenesis.

Guilford, CT, USA

Pangolin Therapeutics

Connecticut Innovations provides strategic capital and operational insight to push the frontiers of high-tech industries such as energy, biotechnology, information technology, and photonics. Over the years, CI has helped over 100 emerging companies research, develop, and market new products and services. This activity has attracted over $1 billion dollars in additional investments from private equity providers. CI has brought the State of Connecticut over $510 million in Gross State Profit and over 5,000 additional job-years.

Career Opportunities